Antisense & RNAi Therapeutics Market Report
RA01163
Antisense & RNAi Therapeutics Market, by End Use (Hospitals, Research institutes, Others), Technology (Antisense RNA, RNAi), Disease Type (Cardiovascular, Respiratory diseases, Neurological, Renal, Oncology, Infectious diseases, Genetic disorder, Others), Age Category (Pediatric and pre-neonatal, Adult), Delivery Mode (Pulmonary, Intravenous, Intradermal, Others): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global antisense & rnai therapeutics market is estimated to surpass $2,252.6 million by 2027, exhibiting a CAGR of 8.4% from 2020 to 2027.
The report offers a thorough analysis of global antisense & rnai therapeutics market with detailed study of various aspects of the market such as market dynamics, vital segments, major geographies, key players, and competitive landscape.
The report provides a clear picture of the current market situation and future trends of the global antisense & rnai therapeutics market based on impact of various market dynamics and vital forces influencing the market. The drivers and opportunities in the market contributing to the market growth are acknowledged in the market dynamics. Besides, challenges and restraints that hold potential to hamper the market growth are also premeditated in the global antisense & rnai therapeutics market. Porter’s five forces analysis is delivered through the report which precisely highlights the effects of key forces on the global antisense & rnai therapeutics market.
The report offers market size and estimations analyzing global antisense & rnai therapeutics market through various segments. In addition, the report includes geographical market analysis of these segments. Each segment entailed in the report is studied at regional and country level as well to provide complete coverage of global antisense & rnai therapeutics market. The report categorizes the global antisense & rnai therapeutics market into four major geographies including North America, Europe, Asia-Pacific, and LAMEA. These geographies are further sub-categorized into countries to cover antisense & rnai therapeutics market scenario across in respective regions.
Furthermore, the report covers competitive scenario of the global antisense & rnai therapeutics market. The key players operating in the global antisense & rnai therapeutics market are studied in the report to understand their current market position and competitive strengths in the industry. The report profiles 10 key companies. Moreover, the company profiles include various data-points such as company overview, company executives, recent financials of the company, major growth strategies espoused by company, new initiatives and advancements by company to sustain and mend their position in the global antisense & rnai therapeutics market, and others.
Research Methodology
We offer our clients comprehensive research and analysis based on an extensive variety of factual inputs, which mostly include industry participants’ interviews, reliable statistics, and regional acumen. The in-house market experts play an impactful role in designing analytic models and tools, personalized to the requirements of a market segment. These analytical models and tools sterilize the data and statistics and enrich the accuracy of our advice and recommendations.
For accomplishment of this research report, long hours of discussions and interviews have been conducted, with an extensive range of stakeholders that includes upstream and downstream participants. A number of product type literatures, annual reports, industry releases, and other related documents of key industry contributors have been reviewed, for better understanding of the market. We have executed a mix of primary and secondary research for the market estimates and forecasts. Secondary research formulae the initial phase of our detailed study, where we conduct wide-range data mining, referring to certified data sources such as technical journals, medical journals, independent studies, trade association’s releases, materials published by government and regulatory authorities.
KEY MARKET BENEFITS
- The report is a compilation of detailed information, inputs from industry participants and industry experts across the value chain, and quantitative and qualitative assessment by industry analysts.
- This report provides in-depth analysis of current market trends, governing factors, macro-economic indicators from 2019 to 2027 to identify & understand the prevailing opportunities and the strategic assessment of the growth of the global antisense & rnai therapeutics market.
- The report maps the qualitative sway of various industry factors on market segments as well as geographies.
- The market estimations and size provided in the report are based on a comprehensive analysis of recent & futuristic key developments in the antisense & rnai therapeutics market.
- The growth and development strategies adopted by the prominent industry players are enlisted in the report to understand the competitive scenario of the antisense & rnai therapeutics market.
KEY MARKET SEGMENTS
The global antisense & rnai therapeutics market is segmented on the basis of following:
- End Use: Hospitals, Research institutes, Others
- Technology: Antisense RNA, RNAi
- Disease Type: Cardiovascular, Respiratory diseases, Neurological, Renal, Oncology, Infectious diseases, Genetic disorder, Others
- Age Category: Pediatric and pre-neonatal, Adult
- Delivery Mode: Pulmonary, Intravenous, Intradermal, Others
- Region: North America, Europe, Asia Pacific, and LAMEA.
This segment is further sub-segmented into the following regions:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY MARKET PLAYERS
The global antisense & rnai therapeutics market is consolidated with the presence of large number of key players. These players focus upon innovation and expansion of product portfolios to acquire a competitive edge in the market space. The report summarizes various aspects of all these key players including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.
Players in global antisense & rnai therapeutics market include:
1. Alnylam
2. Mirus Bio
3. Marina Biotech
4. Benitec Biopharma
5. RXi pharmaceuticals
6. Qiagen
7. Genzyme
8. Moderna
9. Sarepta
10. Alexion
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Antisense & RNAi Therapeutics Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Antisense & RNAi Therapeutics Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Antisense & RNAi Therapeutics Market, By Application
5.1. Overview
5.2 Hospitals
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Research institutes
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Others
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Research Dive Exclusive Insights
5.5.1 Market attractiveness
5.5.2 Competition heatmap
-
6. Antisense & RNAi Therapeutics Market, By Distribution Channel
6.1. Overview
6.2 Antisense RNA
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 RNAi
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Research Dive Exclusive Insights
6.4.1 Market attractiveness
6.4.2 Competition heatmap
-
7. Antisense & RNAi Therapeutics Market, By Nature Of Device
7.1. Overview
7.2 Cardiovascular
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Respiratory diseases
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Neurological
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Renal
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Oncology
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Infectious diseases
7.7.1 Definition, key trends, growth factors, and opportunities
7.7.2 Market size analysis, by region, 2020-2027
7.7.3 Market share analysis, by country, 2020-2027
7.8 Genetic disorder
7.8.1 Definition, key trends, growth factors, and opportunities
7.8.2 Market size analysis, by region, 2020-2027
7.8.3 Market share analysis, by country, 2020-2027
7.9 Others
7.9.1 Definition, key trends, growth factors, and opportunities
7.9.2 Market size analysis, by region, 2020-2027
7.9.3 Market share analysis, by country, 2020-2027
7.10 Research Dive Exclusive Insights
7.10.1 Market attractiveness
7.10.2 Competition heatmap
-
8. Antisense & RNAi Therapeutics Market, By Operation
8.1. Overview
8.2 Pediatric and pre-neonatal
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Adult
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Research Dive Exclusive Insights
8.4.1 Market attractiveness
8.4.2 Competition heatmap
-
9. Antisense & RNAi Therapeutics Market, By Surgery Type
9.1. Overview
9.2 Pulmonary
9.2.1 Definition, key trends, growth factors, and opportunities
9.2.2 Market size analysis, by region, 2020-2027
9.2.3 Market share analysis, by country, 2020-2027
9.3 Intravenous
9.3.1 Definition, key trends, growth factors, and opportunities
9.3.2 Market size analysis, by region, 2020-2027
9.3.3 Market share analysis, by country, 2020-2027
9.4 Intradermal
9.4.1 Definition, key trends, growth factors, and opportunities
9.4.2 Market size analysis, by region, 2020-2027
9.4.3 Market share analysis, by country, 2020-2027
9.5 Others
9.5.1 Definition, key trends, growth factors, and opportunities
9.5.2 Market size analysis, by region, 2020-2027
9.5.3 Market share analysis, by country, 2020-2027
9.6 Research Dive Exclusive Insights
9.6.1 Market attractiveness
9.6.2 Competition heatmap
10. Antisense & RNAi Therapeutics Market, By Region
10.1 North America
10.1.1 U.S
10.1.1.1 Market size analysis, By Application, 2020-2027
10.1.1.2 Market size analysis, By Distribution Channel, 2020-2027
10.1.1.3 Market size analysis, By Nature of Device, 2020-2027
10.1.1.4 Market size analysis, By Operation , 2020-2027
10.1.1.5 Market size analysis, By Surgery Type, 2020-2027
10.1.2 Canada
10.1.2.1 Market size analysis, By Application, 2020-2027
10.1.2.2 Market size analysis, By Distribution Channel, 2020-2027
10.1.2.3 Market size analysis, By Nature of Device, 2020-2027
10.1.2.4 Market size analysis, By Operation , 2020-2027
10.1.2.5 Market size analysis, By Surgery Type, 2020-2027
10.1.3 Mexico
10.1.3.1 Market size analysis, By Application, 2020-2027
10.1.3.2 Market size analysis, By Distribution Channel, 2020-2027
10.1.3.3 Market size analysis, By Nature of Device, 2020-2027
10.1.3.4 Market size analysis, By Operation , 2020-2027
10.1.3.5 Market size analysis, By Surgery Type, 2020-2027
10.1.4 Research Dive Exclusive Insights
10.1.4.1 Market attractiveness
10.1.4.2 Competition heatmap
10.2 Europe
10.2.1 Germany
10.2.1.1 Market size analysis, By Application, 2020-2027
10.2.1.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.1.3 Market size analysis, By Nature of Device, 2020-2027
10.2.1.4 Market size analysis, By Operation , 2020-2027
10.2.1.5 Market size analysis, By Surgery Type, 2020-2027
10.2.2 UK
10.2.2.1 Market size analysis, By Application, 2020-2027
10.2.2.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.2.3 Market size analysis, By Nature of Device, 2020-2027
10.2.2.4 Market size analysis, By Operation , 2020-2027
10.2.2.5 Market size analysis, By Surgery Type, 2020-2027
10.2.3 France
10.2.3.1 Market size analysis, By Application, 2020-2027
10.2.3.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.3.3 Market size analysis, By Nature of Device, 2020-2027
10.2.3.4 Market size analysis, By Operation , 2020-2027
10.2.3.5 Market size analysis, By Surgery Type, 2020-2027
10.2.4 Spain
10.2.4.1 Market size analysis, By Application, 2020-2027
10.2.4.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.4.3 Market size analysis, By Nature of Device, 2020-2027
10.2.4.4 Market size analysis, By Operation , 2020-2027
10.2.4.5 Market size analysis, By Surgery Type, 2020-2027
10.2.5 Italy
10.2.5.1 Market size analysis, By Application, 2020-2027
10.2.5.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.5.3 Market size analysis, By Nature of Device, 2020-2027
10.2.5.4 Market size analysis, By Operation , 2020-2027
10.2.5.5 Market size analysis, By Surgery Type, 2020-2027
10.2.6 Rest of Europe
10.2.6.1 Market size analysis, By Application, 2020-2027
10.2.6.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.6.3 Market size analysis, By Nature of Device, 2020-2027
10.2.6.4 Market size analysis, By Operation , 2020-2027
10.2.6.5 Market size analysis, By Surgery Type, 2020-2027
10.2.7 Research Dive Exclusive Insights
10.2.7.1 Market attractiveness
10.2.7.2 Competition heatmap
10.3 Asia-Pacific
10.3.1 China
10.3.1.1 Market size analysis, By Application, 2020-2027
10.3.1.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.1.3 Market size analysis, By Nature of Device, 2020-2027
10.3.1.4 Market size analysis, By Operation , 2020-2027
10.3.1.5 Market size analysis, By Surgery Type, 2020-2027
10.3.2 Japan
10.3.2.1 Market size analysis, By Application, 2020-2027
10.3.2.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.2.3 Market size analysis, By Nature of Device, 2020-2027
10.3.2.4 Market size analysis, By Operation , 2020-2027
10.3.2.5 Market size analysis, By Surgery Type, 2020-2027
10.3.3 India
10.3.3.1 Market size analysis, By Application, 2020-2027
10.3.3.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.3.3 Market size analysis, By Nature of Device, 2020-2027
10.3.3.4 Market size analysis, By Operation , 2020-2027
10.3.3.5 Market size analysis, By Surgery Type, 2020-2027
10.3.4 Australia
10.3.4.1 Market size analysis, By Application, 2020-2027
10.3.4.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.4.3 Market size analysis, By Nature of Device, 2020-2027
10.3.4.4 Market size analysis, By Operation , 2020-2027
10.3.4.5 Market size analysis, By Surgery Type, 2020-2027
10.3.5 South Korea
10.3.5.1 Market size analysis, By Application, 2020-2027
10.3.5.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.5.3 Market size analysis, By Nature of Device, 2020-2027
10.3.5.4 Market size analysis, By Operation , 2020-2027
10.3.5.5 Market size analysis, By Surgery Type, 2020-2027
10.3.6 Rest of Asia-Pacific
10.3.6.1 Market size analysis, By Application, 2020-2027
10.3.6.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.6.3 Market size analysis, By Nature of Device, 2020-2027
10.3.6.4 Market size analysis, By Operation , 2020-2027
10.3.6.5 Market size analysis, By Surgery Type, 2020-2027
10.3.7 Research Dive Exclusive Insights
10.3.7.1 Market attractiveness
10.3.7.2 Competition heatmap
10.4 LAMEA
10.4.1 Brazil
10.4.1.1 Market size analysis, By Application, 2020-2027
10.4.1.2 Market size analysis, By Distribution Channel, 2020-2027
10.4.1.3 Market size analysis, By Nature of Device, 2020-2027
10.4.1.4 Market size analysis, By Operation , 2020-2027
10.4.1.5 Market size analysis, By Surgery Type, 2020-2027
10.4.2 Saudi Arabia
10.4.2.1 Market size analysis, By Application, 2020-2027
10.4.2.2 Market size analysis, By Distribution Channel, 2020-2027
10.4.2.3 Market size analysis, By Nature of Device, 2020-2027
10.4.2.4 Market size analysis, By Operation , 2020-2027
10.4.2.5 Market size analysis, By Surgery Type, 2020-2027
10.4.3 UAE
10.4.3.1 Market size analysis, By Application, 2020-2027
10.4.3.2 Market size analysis, By Distribution Channel, 2020-2027
10.4.3.3 Market size analysis, By Nature of Device, 2020-2027
10.4.3.4 Market size analysis, By Operation , 2020-2027
10.4.3.5 Market size analysis, By Surgery Type, 2020-2027
10.4.4 South Africa
10.4.4.1 Market size analysis, By Application, 2020-2027
10.4.4.2 Market size analysis, By Distribution Channel, 2020-2027
10.4.4.3 Market size analysis, By Nature of Device, 2020-2027
10.4.4.4 Market size analysis, By Operation , 2020-2027
10.4.4.5 Market size analysis, By Surgery Type, 2020-2027
10.4.5 Rest of LAMEA
10.4.5.1 Market size analysis, By Application, 2020-2027
10.4.5.2 Market size analysis, By Distribution Channel, 2020-2027
10.4.5.3 Market size analysis, By Nature of Device, 2020-2027
10.4.5.4 Market size analysis, By Operation , 2020-2027
10.4.5.5 Market size analysis, By Surgery Type, 2020-2027
10.4.6 Research Dive Exclusive Insights
10.4.6.1 Market attractiveness
10.4.6.2 Competition heatmap
11. Competitive Landscape
11.1 Top winning strategies, 2020-2027
11.1.1 By strategy
11.1.2 By year
11.2 Strategic overview
11.3 Market share analysis, 2020-2027
12. Company Profiles
12.1 Alnylam
12.1.1 Overview
12.1.2 Business segments
12.1.3 Product portfolio
12.1.4 Financial performance
12.1.5 Recent developments
12.1.6 SWOT analysis
12.2 Mirus Bio
12.2.1 Overview
12.2.2 Business segments
12.2.3 Product portfolio
12.2.4 Financial performance
12.2.5 Recent developments
12.2.6 SWOT analysis
12.3 Marina Biotech
12.3.1 Overview
12.3.2 Business segments
12.3.3 Product portfolio
12.3.4 Financial performance
12.3.5 Recent developments
12.3.6 SWOT analysis
12.4 Benitec Biopharma
12.4.1 Overview
12.4.2 Business segments
12.4.3 Product portfolio
12.4.4 Financial performance
12.4.5 Recent developments
12.4.6 SWOT analysis
12.5 RXi pharmaceuticals
12.5.1 Overview
12.5.2 Business segments
12.5.3 Product portfolio
12.5.4 Financial performance
12.5.5 Recent developments
12.5.6 SWOT analysis
12.6 Qiagen
12.6.1 Overview
12.6.2 Business segments
12.6.3 Product portfolio
12.6.4 Financial performance
12.6.5 Recent developments
12.6.6 SWOT analysis
12.7 Genzyme
12.7.1 Overview
12.7.2 Business segments
12.7.3 Product portfolio
12.7.4 Financial performance
12.7.5 Recent developments
12.7.6 SWOT analysis
12.8 Moderna
12.8.1 Overview
12.8.2 Business segments
12.8.3 Product portfolio
12.8.4 Financial performance
12.8.5 Recent developments
12.8.6 SWOT analysis
12.9 Sarepta
12.9.1 Overview
12.9.2 Business segments
12.9.3 Product portfolio
12.9.4 Financial performance
12.9.5 Recent developments
12.9.6 SWOT analysis
12.10 Alexion
12.10.1 Overview
12.10.2 Business segments
12.10.3 Product portfolio
12.10.4 Financial performance
12.10.5 Recent developments
12.10.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
